Cleared Traditional

K912561 - NOVA 13 ANALYZER

K912561 is an FDA 510(k) clearance for NOVA 13 ANALYZER, manufactured by Nova Biomedical Corp.. The device is a Class 2 Chemistry device with product code CGZ cleared through the Traditional 510(k) pathway after a 92-day FDA review.

K912561 · Nova Biomedical Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1991
Decision
92d
Days
Class 2
Risk

K912561 is an FDA 510(k) clearance for the NOVA 13 ANALYZER. Classified as Electrode, Ion-specific, Chloride (product code CGZ), Class II - Special Controls.

Submitted by Nova Biomedical Corp. (Walham, US). The FDA issued a Cleared decision on September 11, 1991 after a review of 92 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1170 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Nova Biomedical Corp. devices

FDA 510(k) Submission Details - K912561

510(k) Number K912561 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 11, 1991
Decision Date September 11, 1991
Days to Decision 92 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
4d slower than avg
Panel avg: 88d · This submission: 92d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CGZ Device Classification - Class 2, Special Controls

Product Code CGZ Electrode, Ion-specific, Chloride
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1170
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGZ Electrode, Ion-specific, Chloride

All 34
Devices cleared under the same product code (CGZ) and FDA review panel - the closest regulatory comparables to K912561.
HICHEM ISEKCI SOLUTION KIT 70010
K953862 · Hichem Diagnostics · Sep 1995
MODEL 644 SWEAT DILUENT
K935228 · Ciba Corning Diagnostics Corp. · Aug 1994
NOVA 13 ANALYZER, MODIFICATION
K924864 · Nova Biomedical Corp. · Nov 1992
ISE/CI-
K912647 · Boehringer Mannheim Corp. · Jul 1991
ABBOTT SPECTRUM AUTOMATED CLINICAL CHEM. ANALYZER
K900887 · Abbott Laboratories · May 1990
OLYMPUS ISE MODULE FOR AU5000
K893628 · Olympus Corp. · Aug 1989